Images
Participants
Contact
“20 minutos” newspaper publishes a compilation of the most important findings in made in biomedicine in 2014 by leading research centres in Spain. The article emphasizes that these results, produced by CNIC, CNIO, Vall d’Hebron and IRB Barcelona, were achieved despite the economic crisis.
Regarding IRB Barcelona, one of the outstanding projects is that undertaken by the team led by Ángel Rodríguez Nebreda, head of the “Signalling and Cell Cycle” lab, which identified the function of a protein related to colon cancer. The article also highlights the project developed by the group led by Roger Gomis, ICREA researcher and head of the “Growth Control and Cancer Metastasis” lab, which has identified the genes that favour the staggered metastasis of colon cancer.
Read the article in “20 minutos” (in Spanish).
About IRB Barcelona
The Institute for Research in Biomedicine (IRB Barcelona) pursues a society free of disease. To this end, it conducts multidisciplinary research of excellence to cure cancer and other diseases linked to ageing. It establishes technology transfer agreements with the pharmaceutical industry and major hospitals to bring research results closer to society, and organises a range of science outreach activities to engage the public in an open dialogue. IRB Barcelona is an international centre that hosts 400 researchers and more than 30 nationalities. Recognised as a Severo Ochoa Centre of Excellence since 2011, IRB Barcelona is a CERCA centre and member of the Barcelona Institute of Science and Technology (BIST).
